Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Baoling Bio logo — Leading the future of drug discovery with a focus on innovat...

Baoling Bio

Leading the future of drug discovery with a focus on innovative treatments for tumors, autoimmune diseases, and cytokine storms.

Founded 2019 Series B Total: $106.50M Biopharma, Biotechnology +1

General Information

Company Name Baoling Bio
Founded Year 2019
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Baoling Bio. To contact Baoling Bio, visit zenitar.com.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Baoling Bio

Baoling Bio is a biopharmaceutical startup founded in 2019 with a focus on innovative treatments for tumors, autoimmune diseases, and cytokine storms. The company is at the forefront of drug research, development, and industrialization within the biopharma, biotechnology, and pharmaceutical industries. Their pioneering development pipeline includes promising treatments for conditions such as tumors (both solid and hematomas), autoimmune diseases, and cytokine storms induced by new coronavirus pneumonia. The company recently secured a significant Series B investment on 24 November 2023 from a consortium of notable investors including Si Chuan Venture Capital, Acusea/Huiyuan Capital, Chengdu High-tech Ceyuan Capital, West China Precision Medicine Industry Innovation Center, and Shengzhong Investment. Baoling Bio is poised to make a substantial impact in advancing drug discovery and treatment innovations in critical medical areas.

Taxonomy: drug discovery, tumor treatments, autoimmune diseases, cytokine storms, innovative drug research, development pipeline, industrialization, solid tumors, hematomas, coronavirus pneumonia, service provider

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B Undisclosed 5
Si Chuan Venture Capital Acusea/Huiyuan Capital Chengdu High-tech Ceyuan Capital
Si Chuan Venture Capital, Acusea/Huiyuan Capital +3
24 Nov 2023
Series A CNY106.50M 4
Si Chuan Venture Capital
Si Chuan Venture Capital, New Value Capital +2
08 Dec 2021

Baoling Bio Alternatives & Competitors

View All Alternatives
Baoling Bio vs
Yuyao Biotech
Yuyao Biotech

Advancing healthcare with innovative AI-driven solutions for hematological tumors, neurodegenerative...

Seed
Biopharma, Biotechnology
Baoling Bio vs
Huasaiboman Medical Cell Biology
Huasaiboman Medical Cell Biology

Pioneering tomorrow's treatments for solid tumors and degenerative diseases through state-of-the-art...

Series A
Biotechnology, Life Sciences
Baoling Bio vs
Ventus Therapeutics
Ventus Therapeutics United States

Pioneering a unique approach to structure-based drug discovery. Located in Waltham, MA and Montreal,...

Grant
55 employees
Biotechnology, Health Care
View all alternatives

FAQ About Baoling Bio

Leading the future of drug discovery with a focus on innovative treatments for tumors, autoimmune diseases, and cytokine storms.
Baoling Bio was founded in 2019.
Baoling Bio operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on drug discovery, tumor treatments, autoimmune diseases and cytokine storms.
Baoling Bio has completed 2 funding rounds, raising a total of $106.50M. The latest funding stage is Series B.
Top alternatives and competitors to Baoling Bio include Yuyao Biotech, Huasaiboman Medical Cell Biology, Ventus Therapeutics, AGY Therapeutics, Sevion Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Baoling Bio and Yuyao Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Baoling Bio, https://bouncewatch.com/company/baoling-bio, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes